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Abstract 
The yeasts Saccharomyces cerevisiae and Schizosaccharomycespombe wer  tested for heterologous expression of the human D,, dopamine receptor. 
The cDNA coding for the dopamine receptor was cloned into high copy number plasmids with inducible promoters. After transformation into the 
yeasts recombinant clones were examined for the presence of functional receptor by radioligand binding using the antagonist [Hjspiperone. 
Subsequent Western blot analysis of positive recombinants with an antiserum raised against a peptide from the third intracellular domain of the 
receptor protein revealed the production of a protein with an apparent molecular mass of 40 kDa in both yeasts. Membranes harvested from 
recombinant yeast clones exhibited saturable binding of the dopaminergic antagonist [‘Hlspiperone with Kd values of 1.3 nM in S. cerevisiae and 
0.25 nM in S. pombe. The rank order of potencies for several dopaminergic ligands to displace specific [3H]spiperone binding to membranes were 
the same in both yeasts, whereas the affinities for ligands differed significantly. 
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1. Introduction 
The essential prerequisite for extensive biochemical, 
biophysical and structural analysis of G-protein coupled 
receptors is the availability of large quantities of homo- 
geneous protein, which cannot be provided by natural 
sources. Hence cloned receptor cDNAs must be overex- 
pressed in suitable heterologous expression systems [l]. 
The genetically well characterized unicellular eucar- 
yote Saccharomyces cerevisiae has been used for the 
heterologous production of several G-protein coupled 
receptors [2,3] (Sander et al., in preparation). Recently, 
the expression of a bacterial membrane protein with 
seven transmembrane spanning regions in a second well 
characterized yeast was reported: bacteriorhodopsin had 
been functionally expressed in the fission yeast 
Schizosaccharomyces pombe [4]. The results presented 
were so convincing, that this unicellular organism was 
also considered as an alternative host for heterologous 
expression of G-protein coupled receptors from higher 
eucaryotes. We report here a comparative study using 
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both yeast genera as expression systems for the heterolo- 
gous production of a member of this receptor superfa- 
mily, the human D,, dopamine receptor. 
The D, receptor was the first dopamine receptor to be 
cloned and is the best characterized one [5,6]. Two 
isoforms of the receptor are known (D,, and D,,), which 
are produced by differential splicing [7-91. Activation of 
the receptor results in various responses, including inhi- 
bition of adenylate cyclase, inhibition of phosphatidyli- 
nositol turnover, increase in K+ channel activity and 
inhibition of Ca2’ mobilization [6,10-131. The distorted 
balance between dopamine and the dopamine receptors 
is thought to be responsible for the development of psy- 
chiatric and neurological disorders such as schizophrenia 
and Parkinson’s disease [14,15]. Antagonism of postsyn- 
aptic D, receptors has long been regarded as the primary 
mechanism of the action of certain antipsychotic drugs. 
The major problems that arose with the use of dopamine 
antagonists were side effects resulting from drug cou- 
pling to other neuroreceptors [ 161. The experimental con- 
firmation of the three-dimensional structure of the D, 
dopamine receptor previously proposed by Dahl et al. 
[17], will not only significantly add to the understanding 
of the molecular mechanism of ligand binding, but will 
also give the possibility to design suitable and specific 
drugs based on the spatial requirements of the ligand 
binding pocket. 
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2. Materials and methods muno blot analysis, proteins were transferred onto a polyvinyliden- 
difluoride membrane (Immobilon P: Millinore) and urocessed as de- 
scribed [26]. The primary polyclonaj antidody’RD2 {directed against 
the receptor) was used at a dilution of 1: 5000, the secondary anti-rabbit 
alkaline phosphatase coupled antibody at a dilution of 1: 1000. Protein 
bands were visualized by enzymatic reaction in AP-buffer (100 mM 
NaCl, 100 mM Tris pH 9.5, 5 mM MgCl,) with BCIP (stock solution: 
50 mg/ml DMF) and NBT (stock solution: 50 mg/ml 70% DMF) as 
recommended by the suppliers. 
2.1. Strains and transformations 
E. coli strain XL-l Blue (recA1, endAl, gyrA96, thi-1, hsdRl7, 
supE44, relA1, lac-, [F’proAB, lacI’?Z4MlS, TnlO(tet’)] (Stratagene) 
was used for propagation of the recombinant plasmids. For E. coli 
transformation, the CaCl, procedure was used as described [18]. S. 
cerevisiae strain YMTAB: (MATa, GAL+, leu2-3,112; u&AS; 
pra::HIS3; prblAAV) was kindly provided by Prof. D.H. Wolf 
(University Stuttgart). The universal transforming strain S. pombe (h-, 
Ural- D18, Zeul-32, ade6-704) was kindly provided by K. Maundrell 
(Glaxo, Geneva). Yeast cells were made competent for plasmid uptake 
by treatment with lithium acetate and polyethylenglycol [19,20]. 
2.2. Recombinant DNA technology and construction of recombinant 
plasmids 
DNA isolation, restriction enzyme analysis, agarose electrophoresis 
and cloning procedures were performed using established techniques 
[18,21]. The plasmid pBSD2YSal used for the following cloning steps 
is described in detail elsewhere (Sander et al., in preparation). Plasmid 
YEpSl, which bears the inducible GAL10 promoter for heterologous 
expression in S. cerevisiae, was used [22]. A San-DNA fragment har- 
bouring the D,, gene was isolated from pBSD2YSal and cloned into 
the SalI site of vector YEp5 1. In the resulting plasmid, YEp5 lD2 (Fig. 
l), the D,, gene is now located downstream of the inducible GAL10 
promoter (YEp51). The vector YEp51 and the recombinant plasmid 
were used for the transformation of S. cerevisiae cells. 
For the expression of the D,, receptor in S. pombe the plasmid 
pREP1 (kindly provided by K. Maundrell, Geneva) was used. This high 
copy number plasmid contains the inducible promoter and the tran- 
scriptional termination sequences of the nmtl gene from S. pombe 
separated by a multiple cloning site for the insertion of foreign genes 
[23]. The D,, gene was isolated from plasmid pBSD2YSal using appro- 
priate BamHI restriction sites flanking the gene and cloned into pREP1 
digested with BamHI and treated with calf intestinate phosphatase 
resulting in pREPlD2. 
2.3. Yeast culture 
Non-transformed S. cerevisiae and S. pombe strains were kept in 
YPD- and YE-medium, respectively. Transformed yeast always was 
cultured under selective pressure. For S. cerevisiae SC medium, for S. 
pombe MM medium containing the required supplements respectively 
was used to counteract he loss of transformed plasmids [24]. 
In S. cerevisiae the expression of the D,, dopamine receptor was 
induced by changing the carbon source in the media of the growing 
culture from 2% glucose to 2% galactose. Prior to induction the S. 
pombe transformants were grown in the presence of 1 PM thiamine. 
Induction of the nmtl promoter was achieved by washing the trans- 
formed cells with sterile water and resuspension i  thiamine-free MM. 
Sixteen hours after induction yeast cells were harvested and membranes 
were isolated as described below. 
2.4. Isolation of membranes from S. cerevisiae and S. pombe cells 
250-ml cultures of yeast cells in the respective growth medium were 
harvested after overnight incubation by centrifugation. Cells were 
washed in water, centrifuged and the pellet was resuspended in 4 ml 
STEDlO-buffer (10 mM Tris-HCl pH 7.6; 1 mM EDTA; 1 mM DDT; 
10% sucrose) supplemented with protease inhibitors (5 pg/ml leupeptin, 
5 pg/ml chymostatin, 1 &ml pepstatin, and 100 mM Pefabloc). Glas 
beads (17 gr; mesh MOO; Sigma) were added to the suspension and 
the cells were broken by vigorous vortexing at 4°C for 5 min. The 
homogenate was diluted with 15 ml of STEDlO-buffer plus protease 
inhibitors and centrifuged at 3,000 x g for 10 min to remove cell debris. 
Subsequently the membranes were pelleted in a Sorvall centrifuge at 
35,000 x g for 45 min. The resulting membrane pellet was resuspended 
in 34 ml STEDlO-buffer and stored at -70°C for further experiments. 
2.5. Western blot analysis 
Membranes were diluted to a protein concentration of 2 pg/pl in 
STEDlO-buffer and incubated for 15 min at room temperature with an 
equal volume of SDS-loading buffer (2% w/v SDS, 5% v/v B-mercap- 
toethanol, 5% v/v glycerol, 62.5 mM Tris-HCl pH 6.8, 0.01% w/v 
Bromophenol blue). After a short centrifugation the membrane pro- 
teins were separated on a 10% SDS polyacrylamide gel [25]. For im- 
2.6. Radioligand binding to recombinant human Dzs receptor 
Saturation binding measurements were performed on isolated mem- 
branes using antagonist [3H]spiperone as a radioactive ligand (spec. 
activity 0.55-1.11 TBq/mmol; DuPont, NEN). Membranes equivalent 
to lo-30 pug protein were suspended in 500 ,ul binding buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl) and radioactive ligand was pipetted 
to the probe at a final concentration of 0.02-20000 pM. Binding assays 
were incubated for 45 min at 30°C. Nonspecific binding was determined 
in the presence of non-labeled (+)butaclamol (2 PM final concentra- 
tion). Bound and free ligand were separated by rapid filtration (What- 
man GF/F filters, soaked in 0.3% polyethyleneimine) and after 3 washes 
with ice-cold binding buffer, radioactivity bound to the filter was deter- 
mined by liquid szintillation counting (rotiszint; Roth). Kd and B,,,,,- 
values were calculated by computer-aided non-linear regression analy- 
sis of the binding isotherms under equilibrium conditions. 
3. Results and discussion 
S. cerevisiae and S. pombe have successfully been used 
for the functional expression of various proteins. To 
compare the heterologous expression of the human D,, 
receptor in the two yeast genera, we constructed two 
recombinant plasmids named YEpSlD2 and pREPD2 
for the transformation of S. cerevisiae and S. pombe, 
respectively. In both constructs the coding region of the 
Dzs receptor was placed under the transcriptional con- 
trol of a strong, inducible promoter. In plasmid 
YEpSlD2 which was used for transformation of S. cere- 
visiae the yeast GAL10 promoter [22], and in plasmid 
pREPlD2 which was used transformation of S. pombe, 
the nmtl promoter [23], directed transcription of the for- 
eign gene (Fig. 1). In both constructs the region for initi- 
ation of translation has been optimized for the expres- 
sion in the yeasts, whereas the D, coding region has not 
been altered during construction. 
Yeast transformants of both genera S. cerevisiae and 
S. pombe carrying the expression plasmids were assayed 
for their ability to bind the dopamine antagonist 
[3H]spiperone. Recombinant clones which scored posi- 
tive during this initial screening were then examined for 
the presence of the D,, dopamine receptor protein by 
Western blot analysis. As a control, transformants har- 
bouring the plasmids without the inserted D,, cDNA 
were examined in parallel. The membrane proteins har- 
vested after induction were separated on 10% SDS-poly- 
acrylamid gels. After transfer of the membrane proteins 
onto Immobilon sheets, the blots were probed with poly- 
clonal antiserum RD2 directed against a peptide occur- 
ring in the third intracellular loop of the human D,, 
receptor (Sander et al., in preparation). 
Membrane preparations from recombinant S. cere- 
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Fig. 1. Expression plasmids constructed for the heterologous expression of the human D,, dopamine receptor in S. cerevisiae and S. pombe. (A) Partial 
map of the expression plasmid YEp51D2 for S. cerevisiae. The human D,, receptor gene is under transcriptional control of the yeast GAL10 promoter. 
(B) Partial map of the expression plasmid pREPlD2 for S. pombe. The nmtl promoter controls the heterologous expression of the human Dzs receptor 
gene. ori, origin of replication for E. coli; Amp, ampicillin resistance gene; pUCl19, E. coli plasmid pUC119; ~JI ORI, yeast 2,!~ origin of replication; 
Term, transcriptional termination region; LEU2, LEU2 gene from S. cerevbiae. 
visiae and S. pombe bearing only vectors YEp51 and ing cDNA sequence (47 kDa). An additional protein 
pREP1 respectively, were totally devoid of stainable pro- band migrating at about 43 kDa appears in the mem- 
tein. As presented in Fig. 2A, the antibody specifically brane preparation of receptor producing cells from S. 
stained a protein with an apparent molecular mass of cerevisiae might resemble core-glycosylated receptor 
=40 kDa in both yeasts when transformed with the protein, A band with a similar molecular mass does not 
expression plasmid harbouring the Dzs dopamine recep- appear in preparations from S. pombe, suggesting amore 
tor gene. The apparent molecular mass determined by homogeneous population of heterologously expressed 
SDS-PAGE differs significantly from the molecular mass receptor protein. The Coomassie stain of a gel with the 
which can be calculated from the cDNA sequence (45.5 same membrane preparations did not show any obvious 
kDa) but is the same for both yeasts. It has been reported additional protein band in the range of 40 kDa but 
earlier, that the apparent molecular mass of the isolated clearly demonstrates, that less protein was loaded with 
and deglycosylated rat Dz receptor is -7 kDa smaller the preparations of S. pombe (Fig. 2B). However, the 
than the molecular mass calculated from the correspond- intensity of the immunologically stained protein in the 
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Fig. 2. (A) Western blot analysis of membrane proteins isolated from recombinant yeast cells. (B) Coomassie stain of the same gel (SDS-PAGE of 
membranes prepared from recombinant yeast clones). 1, S. cerevisiae YEpSl; 2, S. cerevisiae YEp51D2; 3, S. pombe pREP1; 4, S. pombe pREPlD2; 
Lane M, marker proteins. 
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Western blot analysis indicated that the concentration of 
the heterologously produced receptor protein was re- 
markably higher in the fission yeast. Strong specific sig- 
nals on the Western blot analysis that arise in the molec- 
ular mass range of =85 kDa in membrane preparations 
of both expressing yeasts most probably represent aggre- 
gated protein, which is produced in the cells due to the 
overexpression of the receptor. The treatment of mem- 
brane preparations with the glycosylase PNGaseF re- 
sulted in no significant changes in the western blot pat- 
tern (data not shown). From this we suggest, that the 
higher molecular mass proteins are not heavily altered by 
addition of carbohydrates. The regular signal pattern 
appearing specially in the membrane preparation of S. 
pombe transformants (Fig. 2A, lane 4) imply that the 
receptor aggregates in the form of multimers. 
Table 1 
Pharmacological profiles for the D,, receptor expressed in S. cerevisiae 
and S. pombe 
Ligand R values 
D,,R in S. cerevisue D,,R in S. pombe 
Apomorphine 1.9 x lo3 1.3 x lo3 
(+)Butaclamol 12.6 5.1 
Domperidone 22.7 10.0 
Dopamine 2.9 x lo5 1.5 x lo5 
Haloperidol 63.4 28.2 
A primary function of a certain cell surface receptor 
is to recognize its appropriate ligands. Total binding 
experiments were conducted to determine the expression 
levels of the receptor proteins in the different trans- 
formed yeasts. The results of the experiments are de- 
picted in Fig. 3, revealing that the receptor expression 
levels in the different yeast genera varied significantly. 
Membranes prepared from transformed S. cerevisiae 
bound ~2.8 pmol ligand per mg of membrane protein 
whereas membranes prepared from transformed S. 
pombe bound up to 214.6 pmol per mg protein. The 3- 
to 5-fold higher receptor concentration monitored in the 
fission yeast could resemble an increased over all expres- 
sion level or a better ratio of functional to non-functional 
receptor proteins. 
Ki values [nM] calculated from IC,, obtained in the competition experi- 
ments depicted in Fig. 5. The K, values were calculated from the ICsO 
values according to the equation K, = IC,(l+C/Kd), where C is the 
concentration of [‘Hlspiperone (1.3 nM) and & is the equilibrium 
dissociation constant of [‘Hlspiperone for the heterologously expressed 
D,, receptor (1.3 nM for S. cerevisiae and 0.25 nM for S. pombe). 
S. pombe cells transformed with YEpSlD2 and 
pREPlD2, respectively, exhibited specific saturable 
binding of [3H]spiperone while control cells transformed 
with the vectors did not show any specific binding. The 
K,, and B,,, values were calculated from saturation iso- 
therms (Fig. 4). The receptors expressed in yeast exhib- 
ited uniform affinity as indicated by the linear slope of 
the Scatchard plot, indicating a single class of binding 
sites. The affinities for [3H]spiperone of the receptors 
expressed in S. cerevisiae (Kd = 1.3 nM) and S. pombe 
(K,, = 0.25 nM) were calculated from a non-linear fit. 
To further establish the functional integrity of the D2s 
receptor expressed in both yeasts, recombinant clones 
were tested for the presence of dopamine binding sites 
using the antagonist [3H]spiperone in saturation experi- 
ments. Membranes prepared from S. cerevisiae and 
The pharmacological profiles for the heterologously 
expressed D,, receptors in S. cerevisiae and S. pompe 
were determined by the replacement of [3H]spiperone 
bound to the membranes with a series of ligands includ- 
ing two agonists (apomorphine and dopamine) and three 
antagonists ((+)butaclamol, domperidone and haloperi- 
dol). The corresponding inhibition constants (Table 1) 
were calculated from the resulting IC,, values from the 
competition curves depicted in Fig. 5. The Ki values for 
all chosen ligands differ by a factor 2 between the two 
yeasts, in general showing a higher affinitiy for the recep- 
tor expressed in S. pombe. Nevertheless, in both expres- 
sion systems the compounds displayed the same rank 
order of potencies: (+)butaclamol > domperidone > ha- 
loperidol > apomorphine > dopamine, which is in agree- 
ment with results published earlier [27]. 
800 t -1 
600 - 
S. cerevisiae S. pombe 
Fig. 3. Total binding of [‘Hlspiperone to membranes prepared from S. 
cerevisiae or S. pombe cells expressing the human D,, dopamine recep- 
tor. Membranes were incubated with a final concentration of 5.1 nM 
[SH]spiperone. Non-specific binding was monitored in the presence of 
10 PM (+)butaclamol. W, YEp51D2 for S. cerevisiae, pREPID for S. 
pombe; 0, YEpSl for S. cerevisiae, pREP1 for S. pombe. 
It should be noted, that the calculated Ki as well as the 
Kd values differ significantly from the values reported 
previously for the receptor in its natural environment or 
heterologously expressed in higher eucaryotic expression 
systems [7,8,28,29]. One possible explanation for this dif- 
ferent binding behaviour may be minor conformational 
changes of the receptor protein forced by the lipid com- 
position of the surrounding membranes. It already has 
been reported that the affinity of a certain receptor is 
very dependent on its environment. So for example, the 
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Fig. 4. Saturation isotherms of [‘Hlspiperone binding to membranes prepared from the yeasts S. cerevisiae (A) and S. pombe (B) transformed with 
plasmids YEp51D2 or pREPlD2, respectively. Membranes were incubated with [3H]spiperone as described in section 2, nonspecific binding was 
determined with 1 PM (+)butaclamol. Inset: scatchard transformation of the data. Data are representative of two independent experiments, with each 
point being measured in triplicate. 
affinity of the serotonin 5HT,, receptor which was 
heterologously expressed in E. coli remained lo- to 40- 
fold below that obtained for the receptor when expressed 
in mammalian systems [30]. However, affinities for the 
ml muscarinic acetylcholine receptor expressed in S. cer- 
evisiae were comparable to those for the same receptor 
in mammalian systems [3]. 
To our knowledge this is the first report of the heterol- 
ogous expression of a G-protein coupled receptor in the 
fission yeast S. pombe. Our results indicate that the fis- 
sion yeast S. pombe is even the more suitable organism 
for the heterologous expression of the human Dzs 
dopamine receptor. Compared to the expression of the 
same receptor protein in the budding yeast S. cerevisiae 
the amount of receptor protein per mg membrane pro- 
120 i 
100 - 
so - 
60 - 
40 - 
20 - 
0 
1 I I, 1 I I I I I I I 
10.13 10.” 1c’ 1c’ lo.” lo“ lo” 
l&and [M] 
tein produced in S. pombe is notably higher. Addition- 
ally, the Kd value for [3H]spiperone binding and the Ki 
values for other specific ligands are lower, when the D,, 
dopamine receptor is expressed in the fission yeast. If in 
general the yeast S. pombe is the better expression system 
for G protein coupled receptors still has to be demon- 
strated. S. pombe has a signal transduction pathway 
which is similar to the pathway in S. cerevisiae [31]. It has 
been previously suggested, that the gpal gene product 
encoding a G, subunit in S. pombe functions as a positive 
mediator in transmitting the signal from the mating fac- 
tor receptor to downstream effecters [32]. However, 
GPAl in S. cerevisiae encodes a G, subunit playing a 
negative role in signal transduction (for review see [33]). 
The mode of function of the G, subunit in S. pombe is, 
B 
120 I I I I , I I I I I , , 
lo.” 1C” 16’ lo.’ 10’3 1c’ 1w’ 
ligand [M] 
Fig. 5. Pharmacological profiles for the Dzs dopamine receptor heterologously expressed in S. cerevisiae (A) and S. pombe (B). Competitive binding 
to membranes from recombinant clones of S. cerevisiae and S. pombe were performed at a final [‘Hlspiperone concentration of 1.3 nM. The 100% 
value corresponds to specific binding in the absence of any competitor and the 0% value corresponds to the nonspecific binding in the presence of 
1 .uM (+)butaclamol. Ligands: (0) apomorphine, (+) (+)butaclamol, (W) domperidone, (0) dopamine, (0) haloperidol. 
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therefore, more like that of the mammalian homologue. 
Thus, it may be more suitable to establish a heterologous 
signal transduction pathway as an assay for drug screen- 
ing in the fission yeast using a reporter protein under the 
control of a promoter which can be turned on by the 
transcription factors activated by agonist coupling. 
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